Sequential improvement of anxiety, depression and anhedonia with sertraline treatment in patients with major depression

Journal of Clinical Pharmacy and Therapeutics

Volumn 25, Issue 5, 2000, Pages 363-371

  Boyer, P ^a   Tassin, J P ^b   Falissart, B ^c   Troy, S ^d  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b INSERM   (France)

^c HÔPITAL PAUL BROUSSE   (France)

^d PFIZER INC   (United States)

Author keywords

Anhedonia; Anxiety; Depression; Efficacy; Sequential improvement; Sertraline

Indexed keywords

ANTIDEPRESSANT AGENT; SERTRALINE;

ADULT; AGED; ANHEDONIA; ANXIETY; ARTICLE; CLINICAL TRIAL; CLUSTER ANALYSIS; DEPRESSION; DRUG EFFECT; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; SCORING SYSTEM; SINGLE BLIND PROCEDURE;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; ANXIETY; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; SEROTONIN UPTAKE INHIBITORS; SERTRALINE;

EID: 0034530182     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2710.2000.00302.x     Document Type: Article

References (30)

1. The biochemistry of affective disorders
2. The catecholamine hypothesis of affective disorders: A review of supporting evidence
3. Involvement of serotonin and dopamine in the mechanism of action of novel antidepressant drugs: A review
4. Interrelations entre les neuromediateurs impliques dans la depression et les antidepresseurs
5. Integrating the monoamine systems
6. Sertraline in the prevention of depression
7. Sertraline safety and efficacy in major depression: A double-blind fixed-dose comparison with placebo
8. A double-blind placebo-controlled multicentre study of sertraline in the acute and continuation treatment of major depression
9. Preclinical evaluation of McN-5707 as a potential antidepressant
10. Comparative pharmacology of selective serotonin reuptake inhibitors (SSRIs)
11. Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes
12. Selective serotonin reuptake inhibitors in affective disorders - I. Basic pharmacology
13. A rating scale for depression
14. Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects
15. The inventory of depressive symptomatology (IDS): Psychometric properties
16. SCL-90: An outpatient psychiatric rating scale - Preliminary report
17. Antidepressant efficacy of sertraline: A double-blind placebo and amytriptyline-controlled, multicenter comparison in outpatients with major depression
18. Double-blind study of the efficacy and safety of sertraline vs fluoxetine in major depression
19. A controlled comparison of sertraline and fluoxetine in acute and continuation therapy of major depression
20. The efficacy and safety of sertraline vs. imipramine in outpatients with major depression: A six-month, parallel, double-blind, multicenter study
21. The anti-depressant effects of sertraline, selective serotonin reuptake inhibitor in depressed patients
22. Predictors of response to SSRIs in patients with major depression
23. Double-blind comparison of sertraline and fluoxetine in the treatment of major depressive episode in out patients
24. A double-blind efficacy and tolerability study of sertraline and moclobemide in atypical depression
25. Serotonin receptor subtypes their evolution and clinical relevance
26. The role of serotonin in panic, anxiety and depression
27. Regulation of glutamic acid decarboxylase mRNA expression in rat brain after sertraline treatment
28. Negative symptoms in schizophrenia: Neurobiological models and treatment response